Gurgaon 20 Years of Experience Hemato-oncology, Stem Cell Transplantation, Haemophilia
Dr. Nitin Sood’s qualifications include:
These advanced qualifications highlight his extensive training and expertise in hematology, oncology, and pathology, making him a highly skilled practitioner in bone marrow transplantation.
Dr. Nitin Sood is a Bone Marrow Transplant specialist at Medanta, with expertise in stem cell transplantation for haematological malignancies, aplastic anaemia, and inherited blood disorders. With over 12 years of BMT practice, Dr. Sood has overseen hundreds of allogeneic and autologous transplant procedures, achieving outcomes that match leading European BMT centres. Training at India’s finest haematology institutes and international BMT programmes has given Dr. Sood expertise in haploidentical transplantation — a rapidly advancing technique that expands donor options. India’s BMT cost ($18,000–$28,000) is 70–80% less than Germany and Turkey, with success rates of 70–80% for leukaemia — making India the leading destination for CIS patients requiring bone marrow transplantation. MediKaya Healthcare has coordinated multiple successful BMT cases for Kazakhstan and Uzbekistan patients.
Experience Overview
Dr. Nitin Sood’s extensive experience spans over two decades in hematology, oncology, and bone marrow transplantation. He has conducted a significant number of autologous and allogeneic stem cell transplants. His training in the UK and India includes specialized qualifications like CCT (Haemato Oncology) and F.R.C. (Pathology), which further enhance his expertise in treating hematological malignancies. Dr. Sood is recognized for his leadership in bone marrow transplants and his work with complex blood disorders, making him one of the leading experts in this field.
Dr. Nitin Sood specialises in the diagnosis and management of:
Patients from Kazakhstan, Uzbekistan, Russia and across the CIS region choose Dr. Nitin Sood at Medanta because:
India’s bone marrow transplant success rate for leukaemia is 70–80% — comparable to leading European centres. Cost in India: $18,000–$28,000 for allogeneic BMT vs $80,000–$120,000 in Germany and $60,000–$90,000 in Turkey. There is zero waiting time at Fortis Memorial and BLK-Max. MediKaya Healthcare has successfully coordinated over 50 BMT cases for CIS patients.
Through MediKaya Healthcare, all international patients from CIS countries receive dedicated Russian-speaking coordination from the moment of first inquiry through to post-treatment follow-up. Dr. Sood’s team at Medanta is experienced in treating international patients and ensures all communication, medical reports, and treatment plans are clearly explained in Russian.
Professional Memberships
Dr. Nitin Sood holds memberships in several prestigious professional organizations, including:
These memberships reflect his active engagement in the medical community and his commitment to staying updated on advancements in hematology, oncology, and bone marrow transplantation.
Languages Spoken
Dr. Nitin Sood is proficient in several languages, typically including:
His ability to communicate fluently in these languages allows him to effectively connect with a diverse patient population, ensuring clear understanding and comfort during consultations and treatment discussions. This multilingual proficiency helps him cater to both domestic and international patients with ease.
A: Allogeneic BMT (matched sibling) costs $18,000–$22,000. Haploidentical (half-matched) BMT costs $22,000–$28,000. Autologous BMT (stem cell rescue) costs $12,000–$18,000. These figures are 60–70% less than European and Turkish BMT centres.
A: Yes. Family members (siblings, parents, children) can donate bone marrow or peripheral stem cells in India. HLA typing is done in Delhi, and the donor spends approximately 2 weeks in India for the full donation process.
A: BMT patients need to stay in India for 4–6 weeks minimum during the transplant and early recovery phase, followed by monthly remote follow-up. A clean room (HEPA-filtered isolation) is provided during the high-risk engraftment period.
A: Yes. Matched sibling BMT offers a cure rate of 80–90% for thalassaemia major in children under 10. India has pioneered thalassaemia BMT for international patients, with results matching the best Italian and Greek centres.
A: India’s top hospitals have access to international bone marrow registries (DKMS, NMDP). Haploidentical transplant from a half-matched family member is also an increasingly successful option offered at major Indian BMT centres.
Доктор Тежиндер Катария — председатель отдела онкологии и лучевой терапии в Medanta The Medicity, Гургаон. Один из ведущих специалистов Индии по лучевой терапии, включая IMRT, IGRT, VMAT и стереотаксическую радиохирургию. Стоимость полного курса лучевой терапии в Индии: $2 500–5 500. В Казахстане: $8 000–14 000 (при ограниченном доступе к современным технологиям). В Германии: $20 000–40 000. Начало лечения: через 3–7 дней после прибытия. Отправьте ваш диагноз и МРТ-снимки — бесплатная консультация за 48 часов.
